MMG Medical Mktg

 

TIDMMMG 
 
RNS Number : 3854T 
Medical Marketing Int'l Group PLC 
04 June 2009 
 

FUNDING UPDATE 
 
 
 
 
4 June 2009 - Medical Marketing International Group plc ("MMI" or the "Company") 
(AIM:MMG), the life sciences company focused on the development of drugs for 
cancer, today provides an update on the funding arrangements of the Company. 
 
 
At the time of its interim results in December 2008, MMI announced that it was 
funded until the end of June 2009. Following the advancement of the Company's 
cost-cutting program, MMI today announces that it now has funds sufficient to 
last until late summer. The Board continues to discuss further funding options 
and will provide a further update when appropriate. 
 
 
The Company also reports that it has not yet resolved the outstanding employment 
claims of David Best. 
 
Enquiries: 
 
 
+-----------------------------------------+-----------------------------------------+ 
| Medical Marketing International Group   | Tel: +44 (0) 1223 477 677               | 
| plc                                     |                                         | 
| Phil Cartmell, Non-executive Chairman   |                                         | 
| Mark Burton, Chief Technical Officer    |                                         | 
| Rob Sprawson, Chief Financial Officer   |                                         | 
+-----------------------------------------+-----------------------------------------+ 
|                                         |                                         | 
+-----------------------------------------+-----------------------------------------+ 
| FinnCap                                 | Tel: +44 (0)20 7600 1658                | 
| Sam Smith/Charlie Cunningham            |                                         | 
+-----------------------------------------+-----------------------------------------+ 
|                                         |                                         | 
+-----------------------------------------+-----------------------------------------+ 
| Financial Dynamics                      | Tel: +44 (0)20 7831 3113                | 
| Emma Thompson                           |                                         | 
+-----------------------------------------+-----------------------------------------+ 
 
 
 
 
 
 
About MMI 
Medical Marketing International Group plc ("MMI") is a life sciences company 
that identifies, acquires and develops world-class compounds and technologies 
for the treatment of cancer. The Company manages the preclinical and early 
clinical development of drug candidates before pursuing licensing partners to 
manage late-stage development. Please visit www.mmigroup.co.uk for further 
information. 
 
 
Notwithstanding the inclusion on this release by MMI of a website address and/or 
another electronic address, MMI does not accept any notices or any other 
documents or communication via its website or other electronic address. All such 
notices, documents or communication shall be in hard copy format only. 
Accordingly the provisions of section 333 Companies Act 2006 allowing persons to 
communicate with MMI electronically shall not apply to MMI. 
 
 
 
 
 
 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 MSCILFVFRFISIIA 
 

Medical Mktg (LSE:MMG)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Medical Mktg (LSE:MMG)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024